Trytosaveabit commented on a stock · Oct 31, 2023 08:10

News

$BioLine Rx(BLRX.US)$ BioLineRx Entered Exclusive License Agreement To Motixafortide In Asia, Advisored By M.S.Q. Ventures; Provides $15M Upfront And Equity Investment Of $14.6M, Up To $50M In Development And Regulatory Milestones, Up To $200M In Commercial Milestones
Benzinga· 3 mins ago

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

3149 Views

Comment

Trytosaveabit

1847Followers

30Following

22KVisitors